A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
Pre-publication versions of this article are available by contacting email@example.com.
|22 Apr 2016||Submitted||Original manuscript|
|18 Jul 2016||Author responded||Author comments - Jacek Hajda|
|Resubmission - Version 2|
|18 Jul 2016||Submitted||Manuscript version 2|
|2 Jan 2017||Reviewed||Reviewer Report - Jean Baptiste Bachet|
|20 Feb 2017||Reviewed||Reviewer Report - Anne M Noonan|
|27 Mar 2017||Author responded||Author comments - Jacek Hajda|
|Resubmission - Version 3|
|27 Mar 2017||Submitted||Manuscript version 3|
|3 Apr 2017||Reviewed||Reviewer Report - Anne M Noonan|
|26 Jun 2017||Author responded||Author comments - Jacek Hajda|
|Resubmission - Version 4|
|26 Jun 2017||Submitted||Manuscript version 4|
|24 Aug 2017||Editorially accepted|
|29 Aug 2017||Article published||10.1186/s12885-017-3604-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.